TABLE 4.
Antimicrobial agent | Resistance frequency (%) |
Mean % | χ2 | P value | |
---|---|---|---|---|---|
Integron-positive isolates (n = 100) | Integron-negative isolates (n = 100) | ||||
Aminoglycosides | |||||
GM | 20 | 25 | 22.5 | 0.1 | >0.05 |
STR | 50 | 37 | 43.5 | 2.93 | >0.05 |
NN | 15 | 6 | 10.5 | 4.5 | <0.05 |
Cephalosporins | |||||
CFP | 31 | 15 | 23 | 6.35 | <0.05 |
CRO | 26 | 27 | 26.5 | 0 | >0.05 |
CZ | 37 | 54 | 40.5 | 5.16 | <0.05 |
β-Lactams | |||||
AM | 75 | 71 | 73 | 0.23 | >0.05 |
Quinolones | |||||
CIP | 36 | 19 | 27.5 | 6.42 | <0.05 |
NOR | 36 | 6 | 21 | 27.12 | <0.05 |
Macrolides | |||||
AZM | 36 | 22 | 29 | 4.1 | <0.05 |
Tetracyclines | |||||
TE | 71 | 67 | 69 | 0.21 | >0.05 |
Sulfonamides | |||||
SXT | 46 | 36 | 41 | 1.67 | >0.05 |
Rifamycins | |||||
RA | 96 | 79 | 87.5 | 11.7 | <0.05 |
Phenicols | |||||
CHL | 79 | 84 | 81.5 | 0.67 | >0.05 |
Carbapenem | |||||
IPM | 0 | 0 | 0 | ||
Lipopeptide | |||||
PB | 2 | 8 | 5 | 2.63 | >0.05 |
Nitrofuran | |||||
F/M | 33 | 46 | 39.5 | 3.01 | >0.05 |
Differences in resistance between the two groups were established using the χ2 test and were considered significant at a P value of <0.05.